Our signature accurately identifies cool gliomas, which have lower proportions of T-cell infiltration and larger proportions of macrophage infiltration, as well as higher expression of immune checkpoint genes such as CTLA4 and IDO. The gene discussed is IDO1; the disease is central nervous system cancer.